Location History:
- San Diego, CA (US) (2001)
- Lincoln, MA (US) (1999 - 2009)
Company Filing History:
4 out of 4 
2 out of 850 
1 out of 7 
Years Active: 1999-2009
Title: Innovations and Achievements of Inventor Stephen J Brand
Introduction
Stephen J Brand is a prolific inventor based in Lincoln, MA, who holds an impressive portfolio of nine patents. His work primarily focuses on pharmaceutical compositions and innovative therapeutic methods for treating diabetes, showcasing his dedication to advancing medical science.
Latest Patents
Among his latest patents, Stephen has developed several critical formulations, including a pharmaceutical composition combining rapamycin and gastrin 17(LEU15). He has also patented a method for treating diabetes that involves compositions and methods for islet neogenesis therapy, which includes epidermal growth factor (EGF) and a gastrin/cholecystokinin (CCK) receptor ligand combined with immunosuppression. These innovations aim to achieve in vivo islet cell regeneration in individuals with preexisting diabetes. His methods demonstrate significant results, such as prolonged periods of increased insulin release, reduced fasting blood glucose levels, and improved glucose tolerance following short-term treatment.
Career Highlights
Stephen's career includes notable tenures at companies like Waratah Pharmaceuticals Inc. and Millennium Pharmaceuticals Limited. Through these positions, he has contributed to significant advancements in pharmaceutical research and development, particularly in diabetes treatment and management.
Collaborations
Throughout his career, Stephen has collaborated with esteemed colleagues, including Ronald V Nardi and Peter J Elliott. This teamwork has fostered an environment of innovation and has helped propel many of his projects forward.
Conclusion
Stephen J Brand's contributions to medical science through his inventive work in pharmaceuticals are noteworthy. With his extensive patents and collaboration with industry experts, he plays a crucial role in the ongoing quest to improve treatments for diabetes and related conditions. His innovative spirit continues to inspire advancements in the healthcare sector.